Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Vascular Surgery

Free Subscription Articles published in Circulation Retrieve available abstracts of 55 articles: HTML format

Single Articles

January 2021
1. O'FEE K, Panza JA, Brown DL
   Association of Inducible Myocardial Ischemia With Long-Term Mortality and Benefit From Coronary Artery Bypass Graft Surgery in Ischemic Cardiomyopathy: Ten-Year Follow-Up of the STICH Trial.
   Circulation. 2021;143:205-207.
   PubMed    
   
   
   December 2020
2. PAL N, Padala S, Klein K
   Letter by Pal et al Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
   Circulation. 2020;142:e501-e502.
   PubMed    
   
   
   
3. BELLEY-COTE EP, Whitlock RP
   Letter by Belley-Cote and Whitlock Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
   Circulation. 2020;142:e503.
   PubMed    
   
   
   
4. MAHMOOD E, Sharkey A, Matyal R, Mahmood F, et al
   Response by Mahmood et al to Letter Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
   Circulation. 2020;142:e504-e505.
   PubMed    
   
   
   November 2020
5. ALEXANDER JH, Smith PK
   Are We At Risk of Depriving Patients Lifesaving Cardiac Surgery?: Implications of the ISCHEMIA Trial for Coronary Artery Bypass Graft Surgery.
   Circulation. 2020;142:1797-1798.
   PubMed    
   
   
   October 2020
6. FRANCHI F, Rollini F, Been L, Briceno M, et al
   Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention
   Circulation. 2020;142:1500-1502.
   PubMed    
   
   
   
7. BENEDETTO U, Gaudino MF, Dimagli A, Gerry S, et al
   Postoperative Atrial Fibrillation and Long-Term Risk of Stroke After Isolated Coronary Artery Bypass Graft Surgery.
   Circulation. 2020;142:1320-1329.
   PubMed     Abstract available
   
   
   
8. DUNN AN, Donnellan E, Johnston DR, Alashi A, et al
   Long-Term Outcomes of Patients With Mediastinal Radiation-Associated Coronary Artery Disease Undergoing Coronary Revascularization With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting.
   Circulation. 2020;142:1399-1401.
   PubMed    
   
   
   
9. LYTLE B, Gaudino M
   Fractional Flow Reserve for Coronary Artery Bypass Surgery.
   Circulation. 2020;142:1315-1316.
   PubMed    
   
   
   August 2020
10. KHALID N, Shlofmitz E, Waksman R
    Letter by Khalid et al Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e76-e77.
    PubMed    
    
    
    
11. VINCENT F, Van Belle E, Susen S
    Letter by Vincent et al Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e80-e81.
    PubMed    
    
    
    
12. O'NEILL WW, Burkhoff D
    Letter by O'Neill and Burkhoff Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e78-e79.
    PubMed    
    
    
    
13. HELGESTAD OKL, Moller S, Moller JE
    Letter by Helgestad et al Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e72-e73.
    PubMed    
    
    
    
14. AMIN AP, Rao SV, Bach RG, Curtis JP, et al
    Response by Amin et al to Letters Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e82-e84.
    PubMed    
    
    
    
15. CHIEFFO A, Gramegna M, Pappalardo F
    Letter by Chieffo et al Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e74-e75.
    PubMed    
    
    
    
16. GARGIULO G, Esposito G, Avvedimento M, Nagler M, et al
    Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial.
    Circulation. 2020;142:441-454.
    PubMed     Abstract available
    
    
    
17. KHAN SU, Singh M, Valavoor S, Khan MU, et al
    Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-Analysis.
    Circulation. 2020 Aug 3. doi: 10.1161/CIRCULATIONAHA.120.046308.
    PubMed     Abstract available
    
    
    July 2020
18. FARIDI KF, Tamez H, Strom JB, Song Y, et al
    Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study.
    Circulation. 2020;142:306-308.
    PubMed    
    
    
    June 2020
19. COLLERAN R, Byrne RA
    Polymer-Free Drug-Eluting Stents: The Importance of the Right Control.
    Circulation. 2020;141:2064-2066.
    PubMed    
    
    
    
20. O'DONOGHUE ML, Murphy SA, Sabatine MS
    The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y12 Inhibitor in Patients after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Circulation. 2020 Jun 19. doi: 10.1161/CIRCULATIONAHA.120.046251.
    PubMed     Abstract available
    
    
    
21. ROFFI M, Guagliumi G, Ibanez B
    The Obstacle Course of Reperfusion for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic.
    Circulation. 2020;141:1951-1953.
    PubMed    
    
    
    
22. DANIELS MJ, Cohen MG, Bavry AA, Kumbhani DJ, et al
    Reperfusion of ST-Segment-Elevation Myocardial Infarction in the COVID-19 Era: Business as Usual?
    Circulation. 2020;141:1948-1950.
    PubMed    
    
    
    
23. CHANDRASHEKHAR Y, Alexander T, Mullasari A, Kumbhani DJ, et al
    Resource and Infrastructure-Appropriate Management of ST-Segment Elevation Myocardial Infarction in Low- and Middle-Income Countries.
    Circulation. 2020;141:2004-2025.
    PubMed     Abstract available
    
    
    
24. MAHMOOD E, Matyal R, Mahmood F, Xu X, et al
    Impact of Left Atrial Appendage Exclusion on Short Term Outcomes In Isolated Coronary Artery Bypass Graft Surgery.
    Circulation. 2020 Jun 3. doi: 10.1161/CIRCULATIONAHA.119.044642.
    PubMed     Abstract available
    
    
    May 2020
25. NAVARESE EP, Khan SU, Kolodziejczak M, Kubica J, et al
    Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52,816 Patients from 12 Randomized Trials.
    Circulation. 2020 May 29. doi: 10.1161/CIRCULATIONAHA.120.046786.
    PubMed     Abstract available
    
    
    
26. JENSEN LO, Maeng M, Raungaard B, Kahlert J, et al
    Randomised Comparison of the Polymer-Free Biolimus-Coated BioFreedom Stent with the Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Orsiro Stent in an All-Comers Population Treated with Percutaneous Coronary Intervention: The SORT OUT IX Trial
    Circulation. 2020 May 21. doi: 10.1161/CIRCULATIONAHA.119.040241.
    PubMed     Abstract available
    
    
    April 2020
27. PICCOLO R, Bruzzese D, Mauro C, Aloia A, et al
    Population Trends in Rates of Percutaneous Coronary Revascularization for Acute Coronary Syndromes Associated with the COVID-19 Outbreak.
    Circulation. 2020 Apr 30. doi: 10.1161/CIRCULATIONAHA.120.047457.
    PubMed    
    
    
    
28. ZHOU X, Li Y, Yang Q
    Antiplatelet Therapy Following Percutaneous Coronary Intervention in Patients Complicated by COVID-19: Implications from Clinical Features to Pathological Findings.
    Circulation. 2020 Apr 16. doi: 10.1161/CIRCULATIONAHA.120.046988.
    PubMed    
    
    
    March 2020
29. PARK DW, Ahn JM, Park H, Yun SC, et al
    Ten-Year Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Disease: Extended Follow-Up of the PRECOMBAT Trial.
    Circulation. 2020 Mar 30. doi: 10.1161/CIRCULATIONAHA.120.046039.
    PubMed    
    
    
    
30. ALFONSO F, Kastrati A
    Ten-Year Follow-Up of Left Main Coronary Artery Revascularization: Still Equipoise Between Percutaneous Interventions and Surgery?
    Circulation. 2020 Mar 30. doi: 10.1161/CIRCULATIONAHA.120.046154.
    PubMed    
    
    
    
31. ALEXANDER JH, Wojdyla D, Vora AN, Thomas L, et al
    The Risk / Benefit Tradeoff of Antithrombotic Therapy in Patients with Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights from AUGUSTUS.
    Circulation. 2020 Mar 29. doi: 10.1161/CIRCULATIONAHA.120.046534.
    PubMed     Abstract available
    
    
    
32. SORRENTINO S, Claessen BE, Chandiramani R, Guedeney P, et al
    Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.
    Circulation. 2020;141:891-901.
    PubMed     Abstract available
    
    
    
33. WANKEN ZJ, Trooboff SW, Gladders B, Columbo JA, et al
    Characterization of Endovascular Abdominal Aortic Aneurysm Repair Surveillance in the Vascular Quality Initiative.
    Circulation. 2020;141:866-868.
    PubMed    
    
    
    February 2020
34. GEWILLIG M, van de Bruaene A
    FUELing the Search for Medical Therapies in Late Fontan Failure.
    Circulation. 2020;141:652-654.
    PubMed    
    
    
    
35. GOLDBERG DJ, Zak V, Goldstein BH, Schumacher KR, et al
    Results of the FUEL Trial.
    Circulation. 2020;141:641-651.
    PubMed     Abstract available
    
    
    December 2019
36. GIUSTINO G, Leon MB, Stone GW
    Highlights of Transcatheter Cardiovascular Therapeutics 2019.
    Circulation. 2019;140:1943-1945.
    PubMed    
    
    
    November 2019
37. AMIN AP, Spertus JA, Curtis JP, Desai N, et al
    The Evolving Landscape of Impella(R) Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention with Mechanical Circulatory Support.
    Circulation. 2019 Nov 17. doi: 10.1161/CIRCULATIONAHA.119.044007.
    PubMed     Abstract available
    
    
    
38. SHAW LJ, Reynolds HR, Picard MH
    A Leap Forward for Ischemia-Guided Revascularization: Stress Echocardiography Predicts Angina Benefit With Percutaneous Coronary Intervention.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044026.
    PubMed    
    
    
    
39. AL-LAMEE RK, Shun-Shin MJ, Howard JP, Nowbar AN, et al
    Dobutamine Stress Echocardiography Ischemia as a Predictor of the Placebo-Controlled Efficacy of Percutaneous Coronary Intervention in Stable Coronary Artery Disease: The Stress Echocardiography-Stratified Analysis of ORBITA.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.042918.
    PubMed    
    
    
    
40. LOPES RD, Leonardi S, Wojdyla DM, Vora AN, et al
    Stent Thrombosis in Patients with Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044584.
    PubMed     Abstract available
    
    
    October 2019
41. GODOY LC, Rao V, Farkouh ME
    Coronary Revascularization of Patients With Diabetes Mellitus in the Setting of Acute Coronary Syndromes.
    Circulation. 2019;140:1233-1235.
    PubMed    
    
    
    
42. GIRI J, Sista AK, Weinberg I, Kearon C, et al
    Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association.
    Circulation. 2019 Oct 4:CIR0000000000000707. doi: 10.1161/CIR.0000000000000707.
    PubMed     Abstract available
    
    
    September 2019
43. BARON SJ, Wang K, Arnold SV, Magnuson EA, et al
    Cost-Effectiveness of Transcatheter Mitral Valve Repair versus Medical Therapy in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial.
    Circulation. 2019 Sep 29. doi: 10.1161/CIRCULATIONAHA.119.043275.
    PubMed     Abstract available
    
    
    
44. WINDECKER S, Lopes RD, Massaro T, Jones-Burton C, et al
    Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial.
    Circulation. 2019 Sep 26. doi: 10.1161/CIRCULATIONAHA.119.043308.
    PubMed     Abstract available
    
    
    
45. SABATE M, Alfonso F, Cequier A, Romani S, et al
    Magnesium-Based Resorbable Scaffold versus Permanent Metallic Sirolimus-Eluting Stent in Patients with ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial.
    Circulation. 2019 Sep 25. doi: 10.1161/CIRCULATIONAHA.119.043467.
    PubMed     Abstract available
    
    
    
46. PARK DW, Kwon O, Jang JS, Yun SC, et al
    Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial.
    Circulation. 2019 Sep 25. doi: 10.1161/CIRCULATIONAHA.119.041766.
    PubMed    
    
    
    
47. VORA AN, Alexander JH, Wojdyla D, Aronson R, et al
    Hospitalization among Patients with Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated with Apixaban or Aspirin: Insights from the AUGUSTUS Trial.
    Circulation. 2019 Sep 25. doi: 10.1161/CIRCULATIONAHA.119.043754.
    PubMed     Abstract available
    
    
    July 2019
48. BRILAKIS ES, Mashayekhi K, Tsuchikane E, Abi Rafeh N, et al
    Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention.
    Circulation. 2019;140:420-433.
    PubMed     Abstract available
    
    
    
49. HE Z, Ding R, Liang C
    Letter by He et al Regarding Article, "Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction: Randomized SHOCK-COOL Trial".
    Circulation. 2019;140:e156-e157.
    PubMed    
    
    
    
50. ZHU J, Peng X, Zheng Z
    Letter by Zhu et al Regarding Article, "Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction: Randomized SHOCK-COOL Trial".
    Circulation. 2019;140:e152-e153.
    PubMed    
    
    
    
51. FUERNAU G, Thiele H
    Response by Fuernau and Thiele to Letters Regarding Article, "Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction: Randomized SHOCK-COOL Trial".
    Circulation. 2019;140:e158-e159.
    PubMed    
    
    
    
52. BENGUEDDACHE S, Bendjelid K
    Letter by Bengueddache and Bendjelid Regarding Article, "Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction: Randomized SHOCK-COOL Trial".
    Circulation. 2019;140:e154-e155.
    PubMed    
    
    
    
53. SIGWART U
    Therapeutic Myocardial Infarction for Hypertrophic Obstructive Cardiomyopathy: Is It Appropriate?
    Circulation. 2019;140:11-12.
    PubMed    
    
    
    June 2019
54. STOUMPOS S, Mark PB
    Should We Ligate Arteriovenous Fistulas in Asymptomatic Patients After Kidney Transplantation?
    Circulation. 2019;139:2819-2821.
    PubMed    
    
    
    May 2019
55. PACKER M, Grayburn PA
    Contrasting Effects of Pharmacological, Procedural and Surgical Interventions on Proportionate and Disproportionate Functional Mitral Regurgitation in Chronic Heart Failure.
    Circulation. 2019 May 1. doi: 10.1161/CIRCULATIONAHA.119.039612.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vascular Surgery is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: